Semler Scientific (NASDAQ:SMLR) Shares Gap Up – Still a Buy?

Semler Scientific, Inc. (NASDAQ:SMLR) gapped up prior to trading on Tuesday . The stock had previously closed at $61.66, but opened at $63.91. Semler Scientific shares last traded at $65.75, with a volume of 76,186 shares trading hands.

Semler Scientific Price Performance

The stock has a market cap of $618.39 million, a P/E ratio of 32.55 and a beta of 1.18. The business’s 50 day simple moving average is $48.65 and its 200 day simple moving average is $36.40.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The firm had revenue of $13.51 million for the quarter.

Institutional Trading of Semler Scientific

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. State Street Corp raised its stake in shares of Semler Scientific by 0.6% during the third quarter. State Street Corp now owns 118,223 shares of the company’s stock worth $2,784,000 after buying an additional 725 shares during the last quarter. Quest Partners LLC boosted its position in shares of Semler Scientific by 48.0% in the 3rd quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock worth $59,000 after purchasing an additional 817 shares during the last quarter. Newbridge Financial Services Group Inc. acquired a new stake in shares of Semler Scientific during the second quarter worth $34,000. US Bancorp DE increased its holdings in Semler Scientific by 60.8% in the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after purchasing an additional 1,158 shares during the last quarter. Finally, Rhumbline Advisers lifted its stake in Semler Scientific by 27.1% in the second quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock valued at $213,000 after buying an additional 1,320 shares during the period. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.